The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, October 17, 2019
PolyPid announced positive top-line results from its Phase 2 clinical trial evaluating D-PLEX100 for the prevention of surgical site infections (SSI) ...
read more
Thursday, October 17, 2019
Viatrexx Bio is voluntarily recalling 10 mL sterile injectable vials of products, listed in the table below with lot numbers, to the consumer level.
read more
Wednesday, October 16, 2019
The FDA has advised consumers not to use Rompe Pecho EX and Rompe Pecho CF cough syrups distributed by Efficient Laboratories due to microbial ...
read more
Thursday, October 10, 2019
ICU Medical has announced a voluntary recall of certain lots of Plum and Sapphire Microbore Infusion Sets with inline filters.
read more
Wednesday, October 09, 2019
Intarcia announced the FDA has accepted the company's resubmission of its NDA for ITCA 650 (exenatide implant), for the treatment of type 2 diabetes ...
read more
Tuesday, October 08, 2019
OWC received TLR of its single-dose, randomized, crossover study to compare the safety, tolerability and pharmacokinetics of Medical Grade Cannabis - ...
read more
ANI announced the receipt of clinical data on Cortrophin® Gel from a study that evaluated the blood-level cortisol response in a 20-person healthy ...
read more
Perrigo announced the relaunch of the AB rated generic equivalent of Transderm Scop® (scopolamine 1.5 mg).
read more
Friday, September 27, 2019
OrbusNeich Medical announced the Japan Ministry of Health, Labour, and Welfare (MHLW) has granted Shonin market approval for the COMBO Plus Coronary ...
read more
Monday, September 23, 2019
Addressing opioid overdose continues to be one of the most urgent public health priorities for the U.S. government and making potentially lifesaving ...
read more
Tuesday, September 17, 2019
Sanofi SA, Abbott Laboratories
Sanofi and Abbott are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with ...
read more
Tuesday, September 17, 2019
Takeda announced the company is issuing a US recall for all doses of NATPARA® (parathyroid hormone) for Injection (25 mcg, 50 mcg, 75 mcg, and 100 mcg...
read more
Monday, September 16, 2019
Gala Therapeutics announced the FDA granted Breakthrough Device Designation for the RheOx Bronchial Rheoplasty system.
read more
Friday, September 13, 2019
Halozyme announced the global phase III FeDeriCa study conducted by Genentech met its primary endpoint.
read more
Wednesday, September 11, 2019
The Metrix Company is recalling specific lots of the empty IV flexible containers due to potential for leaking of the IV bag at the chamber divider ...
read more